Schedule 13G ownership disclosure

STRUCTURE THERAPEUTICS INC

Ordinary Shares, $0.0001 par value · CUSIP: 86366E106

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deep Track Capital, LP

    Shares: 12,335,346.00 · Class: 5.95%

  • Deep Track Biotechnology Master Fund, Ltd.

    Shares: 12,335,346.00 · Class: 5.95%

  • David Kroin

    Shares: 12,335,346.00 · Class: 5.95%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-26-000714
Form type
SCHEDULE 13G/A
Filer
Deep Track Capital, LP
CIK
CIK 1856083
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub